| Help | About | Contact Us

Publication : The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.

First Author	Najumudeen AK	Year	2021
Journal	Nat Genet	Volume	53
Issue	1	Pages	16-26
PubMed ID	33414552	Mgi Jnum	J:302321
Mgi Id	MGI:6508163	Doi	10.1038/s41588-020-00753-3
Citation	Najumudeen AK, et al. (2021) The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat Genet 53(1):16-26

abstractText

Oncogenic KRAS mutations and inactivation of the APC tumor suppressor co-occur in colorectal cancer (CRC). Despite efforts to target mutant KRAS directly, most therapeutic approaches focus on downstream pathways, albeit with limited efficacy. Moreover, mutant KRAS alters the basal metabolism of cancer cells, increasing glutamine utilization to support proliferation. We show that concomitant mutation of Apc and Kras in the mouse intestinal epithelium profoundly rewires metabolism, increasing glutamine consumption. Furthermore, SLC7A5, a glutamine antiporter, is critical for colorectal tumorigenesis in models of both early- and late-stage metastatic disease. Mechanistically, SLC7A5 maintains intracellular amino acid levels following KRAS activation through transcriptional and metabolic reprogramming. This supports the increased demand for bulk protein synthesis that underpins the enhanced proliferation of KRAS-mutant cells. Moreover, targeting protein synthesis, via inhibition of the mTORC1 regulator, together with Slc7a5 deletion abrogates the growth of established Kras-mutant tumors. Together, these data suggest SLC7A5 as an attractive target for therapy-resistant KRAS-mutant CRC.

Expression

Publication --> Expression annotations

Other

43 Authors

Sansom OJ,
CRUK Rosetta Grand Challenge Consortium.,
Murta T,
Tardito S,
Solovyev D,
Dunne PD,
Rodriguez-Blanco G,
Gottlieb E,
Malla SB,
Mackay GM,
Lewis DY,
Hamm G,
Fey SK,
Race AM,
Malviya G,
Nikula CJ,
Nixon C,
Hedley A,
Jackstadt R,
Strathdee D,
Vlahov N,
Dexter A,
Leach JDG,
Goodwin RJA,
Johnson ER,
Najumudeen AK,
Bushell M,
Ridgway RA,
Knight JRP,
Bunch J,
Mrowinska A,
Brown G,
Barry ST,
Gilroy K,
Critchlow SE,
Ceteci F,
Takats Z,
Sumpton D,
Steven RT,
Hall H,
Gay DM,
Clark W,
Campbell AD

23 Bio Entities

0 Expression

Questions? Comments? Click here!

MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Your name:
Your email address:
Subject:
Message:	---- Current page: ---- /mousemine/report.do?id=74125334

MouseMine